Ana Stegic - Net Worth and Insider Trading
Ana Stegic Net Worth
The estimated net worth of Ana Stegic is at least $10,335 dollars as of 2024-09-21. Ana Stegic is the Senior Officer of Antibe Therapeutics Inc and owns about 35,033 shares of Antibe Therapeutics Inc (TSX:ATE) stock worth over $10,335. Details can be seen in Ana Stegic's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Ana Stegic has not made any transactions after 2022-05-06 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Ana Stegic
Ana Stegic Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Ana Stegic owns 1 companies in total, including Antibe Therapeutics Inc (TSX:ATE) .
Click here to see the complete history of Ana Stegic’s form 4 insider trades.
Insider Ownership Summary of Ana Stegic
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
TSX:ATE | Antibe Therapeutics Inc | 2022-05-06 | Senior Officer |
Ana Stegic Latest Holdings Summary
Ana Stegic currently owns a total of 1 stock. Ana Stegic owns 35,033 shares of Antibe Therapeutics Inc (TSX:ATE) as of May 6, 2022, with a value of $10,335.
Latest Holdings of Ana Stegic
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
TSX:ATE | Antibe Therapeutics Inc | 2022-05-06 | 35,033 | 0.30 | 10,335 |
Holding Weightings of Ana Stegic
Ana Stegic Form 4 Trading Tracker
According to the SEC Form 4 filings, Ana Stegic has made a total of 3 transactions in Antibe Therapeutics Inc (TSX:ATE) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Antibe Therapeutics Inc is the acquisition of 28,500 shares on May 6, 2022, which cost Ana Stegic around $19,950.
Insider Trading History of Ana Stegic
- 1
Ana Stegic Trading Performance
GuruFocus tracks the stock performance after each of Ana Stegic's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Ana Stegic is -23.27%. GuruFocus also compares Ana Stegic's trading performance to market benchmark return within the same time period. The performance of stocks bought by Ana Stegic within 3 months outperforms 0 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Ana Stegic's insider trading performs compared to the benchmark.
Performance of Ana Stegic
Ana Stegic Ownership Network
Ana Stegic Owned Company Details
What does Antibe Therapeutics Inc do?
Who are the key executives at Antibe Therapeutics Inc?
Ana Stegic is the Senior Officer of Antibe Therapeutics Inc. Other key executives at Antibe Therapeutics Inc include Director & Director or Senior Officer of 10% Security Holder & Senior Officer John Lawrence Wallace , Senior Officer Joseph Stauffer , and Senior Officer Scott Wilson Curtis .
Antibe Therapeutics Inc (TSX:ATE) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Antibe Therapeutics Inc (TSX:ATE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Antibe Therapeutics Inc (TSX:ATE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Antibe Therapeutics Inc (TSX:ATE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Antibe Therapeutics Inc Insider Transactions
Ana Stegic Mailing Address
Above is the net worth, insider trading, and ownership report for Ana Stegic. Currently GuruFocus does not have mailing address information for Ana Stegic.